Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Bart Roelf Jan van Dijken

6PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Medical biochemistry - inorganic elements and compoundsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Oct 28, 2023
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?

Bart R J van Dijken, Annerieke R Doff, Roelien H Enting

|Sep 09, 2023
The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma.

Bart R J van Dijken, Hanne-Rinck Jeltema, Justyna Kłos

|May 03, 2023
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.

Jesse D de Groot, Bart R J van Dijken, Hiska L van der Weide

|Feb 25, 2022
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.

Bart R J van Dijken, Alfred O Ankrah, Gilles N Stormezand

|Jun 11, 2021
Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.

Bart R J van Dijken, Bram Schuuring, Hanne-Rinck Jeltema

|Jan 11, 2021
Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation.

Bart Roelf Jan van Dijken, A van der Hoorn

Pageof 1

Frequent Collaborators

3 joint publications

Anouk van der Hoorn

2 joint publications

Hanne-Rinck Jeltema

1 joint publications

Wilfred F A Den Dunnen

Frequent Collaborators

3 joint publications

Anouk van der Hoorn

2 joint publications

Hanne-Rinck Jeltema

1 joint publications

Wilfred F A Den Dunnen

Top Related Videos

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on : Jul 05, 2021

3.7K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on : May 31, 2020

5.9K
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on : Jan 07, 2019

9.0K
See more related videos

Top Related Videos

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on : Jul 05, 2021

3.7K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on : May 31, 2020

5.9K
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
06:48

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images

Published on : Jan 07, 2019

9.0K
See more related videos